Skip to content
HowShorted

Global Blood Therapeutics, Inc. short interest in 2019

In 2019, Global Blood Therapeutics, Inc.'s disclosed short interest ran from 15.97% of shares outstanding on 15 Jan 2019 to 13.09% on 31 Dec 2019, a change of -2.88 percentage points. The year's high was 15.97% on 15 Jan 2019 and its low 11.67% on 13 Sep 2019, averaging 13.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.76 days on 31 Jan 2019. Full history: Global Blood Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Global Blood Therapeutics, Inc. in 2019

2019 in figures

Start of year
15.97% (15 Jan 2019)
End of year
13.09% (31 Dec 2019)
Change
-2.88 pp
High
15.97% (15 Jan 2019)
Low
11.67% (13 Sep 2019)
Average
13.84%
Highest days to cover
14.76 (31 Jan 2019)
SEC filings marked
8

Every report in 2019

Global Blood Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201915.97%10.02
31 Jan 201915.21%14.76
15 Feb 201915.18%14.57
28 Feb 201915.47%11.3010-K filed, results (8-K)
15 Mar 201915.32%10.06
29 Mar 201915.88%14.31
15 Apr 201915.34%14.19
30 Apr 201915.05%12.70
15 May 201913.94%12.14results (8-K), 10-Q filed
31 May 201913.61%11.22
14 Jun 201912.21%6.05
28 Jun 201913.69%4.08
15 Jul 201913.28%9.49
31 Jul 201913.01%14.17
15 Aug 201913.00%11.2010-Q filed, results (8-K)
30 Aug 201912.83%9.70
13 Sep 201911.67%6.42
30 Sep 201912.47%9.84
15 Oct 201913.00%10.01
31 Oct 201912.42%13.68
15 Nov 201912.90%10.1510-Q filed, results (8-K)
29 Nov 201913.89%4.02
13 Dec 201913.64%4.72
31 Dec 201913.09%8.07

See also: Global Blood Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.